HACEK endocarditis: state-of-the-art - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Expert Review of Anti-infective Therapy Année : 2016

HACEK endocarditis: state-of-the-art

Résumé

The HACEK group of bacteria - Haemophilus parainfluenzae, Aggregatibacter spp. (A. actinomycetemcomitans, A. aphrophilus, A. paraphrophilus, and A. segnis), Cardiobacterium spp. (C. hominis, C. valvarum), Eikenella corrodens, and Kingella spp. (K. kingae, K. denitrificans) - are fastidious gram-negative bacteria, part of the normal microbiota of oral and upper respiratory tract in humans. Although their pathogenicity is limited, they are responsible for 1-3% of all infective endocarditis. HACEK endocarditis mostly affect patients with underlying heart disease or prosthetic valves, and are characterized by an insidious course, with a mean diagnosis delay of 1 month (Haemophilus spp.) to 3 months (Aggregatibacter and Cardiobacterium spp.). The advent of continuously monitored blood culture systems with enriched media has erased the need for extended incubation for the diagnosis of HACEK endocarditis. Medical treatment relies on third-generation cephalosporin, with a favorable outcome in 80-90% of cases, with or without cardiac surgery
Fichier principal
Vignette du fichier
HACEK endocarditis-1.pdf (219.57 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-01296779 , version 1 (10-06-2016)

Identifiants

Citer

Matthieu Revest, Gérald Egmann, Vincent Cattoir, Pierre Tattevin. HACEK endocarditis: state-of-the-art. Expert Review of Anti-infective Therapy, 2016, 14 (5), pp.523-530. ⟨10.1586/14787210.2016.1164032⟩. ⟨hal-01296779⟩
2526 Consultations
3281 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More